Entero Healthcare s IPO debuted with a discount on BSE and NSE. Proceeds will be used for debt repayment, working capital, funding subsidiaries, and inorganic growth. The company has 73 warehouses and supply relationships with over 1,900 healthcare product manufacturers. The target addressable market is valued at Rs 2.7 lakh crore.
Entero Healthcare Solutions Ltd, which counts healthcare-focussed private equity firm OrbiMed as an investor, made a weak stock market debut Friday with its shares listing at ..
Entero Healthcare Solutions IPO: The debut missed analysts expectations of a 2 percent premium as the IPO had failed to attract investors with the issue getting subscribed only 1.53 times
In the unlisted market, the company s shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut at the bourses. The IPO comprised a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares.